Entertainment
Compare Stocks
2 / 10Stock Comparison
AGAE vs GENI
Revenue, margins, valuation, and 5-year total return — side by side.
Internet Content & Information
AGAE vs GENI — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Entertainment | Internet Content & Information |
| Market Cap | $20M | $1.17B |
| Revenue (TTM) | $8M | $669M |
| Net Income (TTM) | $-5.38B | $-112M |
| Gross Margin | 0.1% | 22.9% |
| Operating Margin | -397.2% | -18.1% |
| Forward P/E | — | 52.4x |
| Total Debt | $31M | $30M |
| Cash & Equiv. | $59M | $281M |
AGAE vs GENI — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Oct 20 | May 26 | Return |
|---|---|---|---|
| Allied Gaming & Ent… (AGAE) | 100 | 54.2 | -45.8% |
| Genius Sports Limit… (GENI) | 100 | 47.4 | -52.6% |
Price return only. Dividends and distributions are not included.
Quick Verdict: AGAE vs GENI
Each card shows where this stock fits in a portfolio — not just who wins on paper.
AGAE is the clearest fit if your priority is efficiency.
- -5.0% ROA vs GENI's -11.1%, ROIC -24.4% vs -16.6%
GENI carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 1 yrs, beta 1.50
- Rev growth 31.0%, EPS growth -63.0%, 3Y rev CAGR 25.2%
- -52.4% 10Y total return vs AGAE's -94.6%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 31.0% revenue growth vs AGAE's 18.6% | |
| Quality / Margins | -16.7% margin vs AGAE's -290.2% | |
| Stability / Safety | Beta 1.50 vs AGAE's 2.81, lower leverage | |
| Dividends | Tie | Neither stock pays a meaningful dividend |
| Momentum (1Y) | -53.1% vs AGAE's -60.3% | |
| Efficiency (ROA) | -5.0% ROA vs GENI's -11.1%, ROIC -24.4% vs -16.6% |
AGAE vs GENI — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
AGAE vs GENI — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
GENI leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
GENI is the larger business by revenue, generating $669M annually — 82.4x AGAE's $8M. Profitability is closely matched — net margins range from -16.7% (GENI) to -2.9% (AGAE). On growth, AGAE holds the edge at +852.5% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $8M | $669M |
| EBITDAEarnings before interest/tax | -$6.7B | -$50M |
| Net IncomeAfter-tax profit | -$5.4B | -$112M |
| Free Cash FlowCash after capex | -$9.1B | $37M |
| Gross MarginGross profit ÷ Revenue | +0.1% | +22.9% |
| Operating MarginEBIT ÷ Revenue | -4.0% | -18.1% |
| Net MarginNet income ÷ Revenue | -2.9% | -16.7% |
| FCF MarginFCF ÷ Revenue | -4.9% | +5.5% |
| Rev. Growth (YoY)Latest quarter vs prior year | +852.5% | +37.0% |
| EPS Growth (YoY)Latest quarter vs prior year | -27.3% | +33.8% |
Valuation Metrics
GENI leads this category, winning 2 of 3 comparable metrics.
Valuation Metrics
| Metric | ||
|---|---|---|
| Market CapShares × price | $20M | $1.2B |
| Enterprise ValueMkt cap + debt − cash | -$8M | $924M |
| Trailing P/EPrice ÷ TTM EPS | -1.16x | -10.83x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 52.42x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | — | — |
| Price / SalesMarket cap ÷ Revenue | 2.18x | 1.75x |
| Price / BookPrice ÷ Book value/share | 0.25x | 1.68x |
| Price / FCFMarket cap ÷ FCF | — | 18.18x |
Profitability & Efficiency
GENI leads this category, winning 6 of 8 comparable metrics.
Profitability & Efficiency
AGAE delivers a -9.5% return on equity — every $100 of shareholder capital generates $-9 in annual profit, vs $-16 for GENI. GENI carries lower financial leverage with a 0.04x debt-to-equity ratio, signaling a more conservative balance sheet compared to AGAE's 0.40x. On the Piotroski fundamental quality scale (0–9), GENI scores 3/9 vs AGAE's 2/9, reflecting mixed financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -9.5% | -15.5% |
| ROA (TTM)Return on assets | -5.0% | -11.1% |
| ROICReturn on invested capital | -24.4% | -16.6% |
| ROCEReturn on capital employed | -25.6% | -15.3% |
| Piotroski ScoreFundamental quality 0–9 | 2 | 3 |
| Debt / EquityFinancial leverage | 0.40x | 0.04x |
| Net DebtTotal debt minus cash | -$28M | -$250M |
| Cash & Equiv.Liquid assets | $59M | $281M |
| Total DebtShort + long-term debt | $31M | $30M |
| Interest CoverageEBIT ÷ Interest expense | — | -136.57x |
Total Returns (Dividends Reinvested)
GENI leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in GENI five years ago would be worth $2,536 today (with dividends reinvested), compared to $2,185 for AGAE. Over the past 12 months, GENI leads with a -53.1% total return vs AGAE's -60.3%. The 3-year compound annual growth rate (CAGR) favors GENI at 5.5% vs AGAE's -18.2% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +21.8% | -55.8% |
| 1-Year ReturnPast 12 months | -60.3% | -53.1% |
| 3-Year ReturnCumulative with dividends | -45.3% | +17.4% |
| 5-Year ReturnCumulative with dividends | -78.2% | -74.6% |
| 10-Year ReturnCumulative with dividends | -94.6% | -52.4% |
| CAGR (3Y)Annualised 3-year return | -18.2% | +5.5% |
Risk & Volatility
GENI leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
GENI is the less volatile stock with a 1.50 beta — it tends to amplify market swings less than AGAE's 2.81 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. GENI currently trades 34.7% from its 52-week high vs AGAE's 13.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 2.81x | 1.50x |
| 52-Week HighHighest price in past year | $3.79 | $13.73 |
| 52-Week LowLowest price in past year | $0.25 | $3.83 |
| % of 52W HighCurrent price vs 52-week peak | +13.7% | +34.7% |
| RSI (14)Momentum oscillator 0–100 | 58.9 | 45.3 |
| Avg Volume (50D)Average daily shares traded | 13.2M | 5.6M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy |
| Price TargetConsensus 12-month target | — | $12.10 |
| # AnalystsCovering analysts | — | 19 |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | — | 1 |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | +0.0% | 0.0% |
GENI leads in 5 of 6 categories — strongest in Income & Cash Flow and Valuation Metrics.
AGAE vs GENI: Frequently Asked Questions
8 questions · data-driven answers · updated daily
01Is AGAE or GENI a better buy right now?
For growth investors, Genius Sports Limited (GENI) is the stronger pick with 31.
0% revenue growth year-over-year, versus 18. 6% for Allied Gaming & Entertainment Inc. (AGAE). Analysts rate Genius Sports Limited (GENI) a "Buy" — based on 19 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — AGAE or GENI?
Over the past 5 years, Genius Sports Limited (GENI) delivered a total return of -74.
6%, compared to -78. 2% for Allied Gaming & Entertainment Inc. (AGAE). Over 10 years, the gap is even starker: GENI returned -52. 4% versus AGAE's -94. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — AGAE or GENI?
By beta (market sensitivity over 5 years), Genius Sports Limited (GENI) is the lower-risk stock at 1.
50β versus Allied Gaming & Entertainment Inc. 's 2. 81β — meaning AGAE is approximately 87% more volatile than GENI relative to the S&P 500. On balance sheet safety, Genius Sports Limited (GENI) carries a lower debt/equity ratio of 4% versus 40% for Allied Gaming & Entertainment Inc. — giving it more financial flexibility in a downturn.
04Which is growing faster — AGAE or GENI?
By revenue growth (latest reported year), Genius Sports Limited (GENI) is pulling ahead at 31.
0% versus 18. 6% for Allied Gaming & Entertainment Inc. (AGAE). On earnings-per-share growth, the picture is similar: Genius Sports Limited grew EPS -63. 0% year-over-year, compared to -365. 8% for Allied Gaming & Entertainment Inc.. Over a 3-year CAGR, GENI leads at 25. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — AGAE or GENI?
Genius Sports Limited (GENI) is the more profitable company, earning -16.
7% net margin versus -184. 6% for Allied Gaming & Entertainment Inc. — meaning it keeps -16. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: GENI leads at -15. 6% versus -256. 7% for AGAE. At the gross margin level — before operating expenses — AGAE leads at 29. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — AGAE or GENI?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
07Is AGAE or GENI better for a retirement portfolio?
For long-horizon retirement investors, Genius Sports Limited (GENI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding.
Allied Gaming & Entertainment Inc. (AGAE) carries a higher beta of 2. 81 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (GENI: -52. 4%, AGAE: -94. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between AGAE and GENI?
Both stocks operate in the Communication Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
- Sector: Communication Services
- Market Cap > $100B
- Revenue Growth > 18%
- Gross Margin > 13%
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.